NASDAQ:MBOT Microbot Medical (MBOT) Stock Price, News & Analysis $1.06 +0.02 (+1.43%) (As of 07/5/2024 08:52 PM ET) Add Compare Share Share Today's Range$1.03▼$1.0750-Day Range$0.91▼$1.3852-Week Range$0.86▼$2.94Volume67,400 shsAverage Volume1.37 million shsMarket Capitalization$17.01 millionP/E RatioN/ADividend YieldN/APrice Target$7.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Microbot Medical alerts: Email Address Microbot Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside557.3% Upside$7.00 Price TargetShort InterestHealthy2.35% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.71Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.66) to ($0.52) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.86 out of 5 starsMedical Sector565th out of 879 stocksSurgical & Medical Instruments Industry67th out of 95 stocks 3.5 Analyst's Opinion Consensus RatingMicrobot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMicrobot Medical has only been the subject of 1 research reports in the past 90 days.Read more about Microbot Medical's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.35% of the outstanding shares of Microbot Medical have been sold short.Short Interest Ratio / Days to CoverMicrobot Medical has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Microbot Medical has recently increased by 27.53%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldMicrobot Medical does not currently pay a dividend.Dividend GrowthMicrobot Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MBOT. Previous Next 2.1 News and Social Media Coverage News SentimentMicrobot Medical has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Microbot Medical this week, compared to 1 article on an average week.Search InterestOnly 10 people have searched for MBOT on MarketBeat in the last 30 days. This is a decrease of -52% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Microbot Medical insiders have not sold or bought any company stock.Percentage Held by Insiders10.64% of the stock of Microbot Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 16.30% of the stock of Microbot Medical is held by institutions.Read more about Microbot Medical's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Microbot Medical are expected to grow in the coming year, from ($0.66) to ($0.52) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Microbot Medical is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Microbot Medical is -1.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioMicrobot Medical has a P/B Ratio of 2.80. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Microbot Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Porter & CompanyObama wins Presidential debate When I said Obama would seek a third term… They called me a conspiracy theorist, they said it couldn’t happen, that the 22nd Amendment makes it impossible. But as I explained on live radio years ago, “he could have a proxy… while he remains in control of the administration much like Putin did in Russia.” Please, watch this now before it’s too late. About Microbot Medical Stock (NASDAQ:MBOT)Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Read More MBOT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MBOT Stock News HeadlinesJuly 3, 2024 | globenewswire.comMicrobot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical TrialJuly 2, 2024 | americanbankingnews.comMicrobot Medical Inc. (NASDAQ:MBOT) Sees Large Growth in Short InterestJuly 8, 2024 | Crypto 101 Media (Ad)[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… June 20, 2024 | globenewswire.comMicrobot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical TrialJune 17, 2024 | globenewswire.comMicrobot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical TrialJune 4, 2024 | globenewswire.comMicrobot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJune 3, 2024 | globenewswire.comMicrobot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesJune 3, 2024 | globenewswire.comMicrobot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical TrialJuly 8, 2024 | Crypto 101 Media (Ad)[Urgent] Hedge Funds Expect Major Crypto MovesIn the year following Bitcoin’s last Halving event, that happened in May of 2020… Bitcoin shot up over 550%. But that’s not all… May 16, 2024 | investorplace.comMBOT Stock Earnings: Microbot Medical Meets EPS for Q1 2024April 29, 2024 | finanznachrichten.deMicrobot Medical Inc.: Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell HealthApril 29, 2024 | globenewswire.comMicrobot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™April 18, 2024 | msn.comMicrobot Medical (MBOT) Price Target Decreased by 12.50% to 7.14April 16, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Halozyme (HALO), Cognition Therapeutics (CGTX)April 15, 2024 | globenewswire.comMicrobot Medical Shares Status Following Recent Geopolitical EventsMarch 28, 2024 | msn.com3 AI Stocks Wall Street Expects to Return Up to 595% in 2024March 27, 2024 | investorplace.comMBOT Stock Earnings: Microbot Medical Misses EPS for Q4 2023March 16, 2024 | ca.finance.yahoo.comMBOT Apr 2024 3.000 callSee More Headlines Receive MBOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Microbot Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/15/2024Today7/07/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:MBOT CUSIPN/A CIK883975 Webwww.microbotmedical.com Phone(781) 875-3605Fax781-556-5347Employees21Year Founded2010Price Target and Rating Average Stock Price Target$7.00 High Stock Price Target$7.00 Low Stock Price Target$7.00 Potential Upside/Downside+557.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.89) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,740,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-149.24% Return on Assets-115.69% Debt Debt-to-Equity RatioN/A Current Ratio5.92 Quick Ratio5.92 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.38 per share Price / Book2.80Miscellaneous Outstanding Shares15,970,000Free Float12,867,000Market Cap$17.01 million OptionableOptionable Beta1.68 Social Links 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Harel Gadot (Age 51)Co-Founder, President, CEO & Chairman Comp: $813.82kMr. Yoseph Bornstein (Age 65)Co-Founder & Independent Director Comp: $13.12kMs. Rachel Vaknin (Age 44)Chief Financial Officer Comp: $212.97kDr. Simon Sharon MBA (Age 63)MSc, CTO & GM of Microbot Israel Comp: $381.51kDr. Juan Diaz-Cartelle (Age 48)Chief Medical Officer Key CompetitorsAIM ImmunoTechNYSE:AIMCurisNASDAQ:CRISNeuroneticsNASDAQ:STIMModular MedicalNASDAQ:MODDLENSARNASDAQ:LNSRView All Competitors MBOT Stock Analysis - Frequently Asked Questions How have MBOT shares performed this year? Microbot Medical's stock was trading at $1.64 on January 1st, 2024. Since then, MBOT shares have decreased by 35.1% and is now trading at $1.0650. View the best growth stocks for 2024 here. How were Microbot Medical's earnings last quarter? Microbot Medical Inc. (NASDAQ:MBOT) announced its earnings results on Wednesday, May, 15th. The biotechnology company reported ($0.17) EPS for the quarter, hitting the consensus estimate of ($0.17). When did Microbot Medical's stock split? Microbot Medical shares reverse split on Monday, May 9th 2016. The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. How do I buy shares of Microbot Medical? Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Microbot Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include Advanced Micro Devices (AMD), Athersys (ATHX), NVIDIA (NVDA), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO) and Novavax (NVAX). This page (NASDAQ:MBOT) was last updated on 7/8/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredI’m giving you the name of this investment for freeThis key unlocks a new pathway to wealth that has been kept hidden from you for decades. In my new documen...Porter & Company | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Microbot Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Microbot Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBOT Stock Alerts